Drugs for Tuberculosis

Autor:	Charles A. Peloquin, Rocsanna Namdar
Rok vydání:	2018
Předmět:	Polypharmacy medicine.medical_specialty Rifabutin Tuberculosis business.industry Context (language use) medicine.disease Virology Pharmacotherapy medicine Ethionamide Intensive care medicine Adverse effect business Ethambutol medicine.drug
Zdroj:	Drug Interactions in Infectious Diseases: Antimicrobial Drug Interactions ISBN: 9783319724157 Drug Interactions in Infectious Diseases ISBN: 9781617792120
DOI:	10.1007/978-3-319-72416-4_6
Popis:	Tuberculosis (TB) represents one of the classic diseases where combinations of drugs are the cornerstone of therapy. The effective treatment of TB requires the use of multiple agents to avoid the development of resistance, so the prevailing attitude toward polypharmacy in this context is positive (1). However, because patients with TB are often infected with other pathogens, especially HIV, we must reevaluate the potential negative consequences of polypharmacy. This chapter will assess the risk for drug interactions in patients with TB, including drug—drug interactions, drug—food interactions, and interactions associated with overlapping adverse effects.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3180dbbf280aa6171ed1b9646704ed6 https://doi.org/10.1007/978-3-319-72416-4_6 Zobrazit plný text záznamu